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Christopher J. Kwolek, MD, David C. Brewster, MD, and Richard P. Cambria, MD, Boston, Mass
Background: A consequence of endovascular aneurysm repair (EVAR) of anatomically straightforward infrarenal
abdominal aortic aneurysm repair cohort (AAA) is that open aneurysm repair is more commonly performed for complex
anatomy. Complex aneurysm repair with visceral vessel involvement (CAA) or combined aneurysm repair and visceral
vessel reconstruction (VVR) has traditionally been considered to increase morbidity and mortality compared with repair
of infrarenal AAA. This study evaluated contemporary outcomes of open abdominal aneurysm surgery, including AAA,
CAA, and VVR using the National Surgical Quality Improvement Program (NSQIP) database.
Methods: The NSQIP Participant Use File was queried by CPT code to identify patients undergoing AAA, CAA, and VVR
(2005-2008). Comparative analysis of clinical features, technical details and 30-day outcomes was performed using
univariate methods. Logistic regression analysis was used to identify predictors of morbidity and mortality.
Results: A total of 2820 patients underwent AAA and 592 CAA. Renal insufficiency (ie, creatinine >1.4 mg/dL) rates
were similar in AAA and CAA patients, however, more frequent in patients with VVR (51% vs 31% [no bypass]; P< .01).
CAA was less likely to be performed urgently (6.3% vs 9.1%; P < .05) and was associated with increased operative time
(254 100 vs 224 93; P< .01) compared with AAA. Univariate analysis showed that CAA did not increase mortality
(5.7% vs 5.1%; P  .5). CAA slightly increased overall complications (32% vs 27%; P  .01) compared with AAA. 73
(2.5%) AAA and 84 (12%) CAA patients had simultaneous VVR and these patients exhibited a trend toward increased
mortality (8.9% vs 5.2%; P  .07). VVR increased complications (43% (VVR) vs 26% [no bypass]; P < .01), including
ventilation >48 hours (21% [VVR] vs 12% [no bypass]; P < .01), renal failure (7.6% [VVR] vs 4.1% [no bypass]; P 
.04), and sepsis (13% [VVR] vs 6.3% ([no bypass]; P < .01). Multivariate analysis demonstrated that CAA (odds ratio
[OR], 1.3 [95% confidence interval (CI), 1.1-1.6]; P .01) and VVR (OR, 2.2 [95% CI, 1.8-3.6]; P< .01) increased the
odds of any complication. Independent predictors of mortality included dependent functional status (OR, 3.6 [95% CI,
2.3-5.4]; P < .01), elevated pre-op creatinine (OR, 2.9 [95% CI, 2.2-4.0]; P < .01), type II diabetes (OR, 1.6 [95% CI,
1.05-2.4]; P  .03), and age (OR, 1.06 [95% CI, 1.03-1.08]; P < .01). Neither CAA (OR, 1.2 [95% CI, 0.84-1.8]; P 
.3) nor VVR (OR, 1.6 [95% CI, 0.89-2.9]; P  .11) were associated with increased mortality compared with AAA.
Conclusion: In contemporary practice the migration of open repair to increasingly complex cases has been achieved with
30-day mortality essentially equivalent to open repair of infrarenal AAA. Patients who require VVR do sustain increased
complications, in particular renal failure. These data also emphasize the importance of baseline renal insufficiency in
clinical decision making. CAA and VVR are associated with increased morbidity in comparison to AAA repair; however,





















rSince it was first described in 1991,1 endovascular
aneurysm repair (EVAR) has become the predominant
modality for repair of abdominal aortic aneurysms. Similar
to our institutional experience, large administrative data-
base studies indicate that in contemporary practice over
70% of abdominal aortic aneurysms are repaired using
EVAR.2-4 Selection of patients with straightforward anat-
omy and evolution of stent graft technology with expand-
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952ng instructions for use for recently approved devices5-7 has
ed to a change in the population of patients undergoing
pen repair. Open repair is performed on increasingly com-
lex morphology such as juxtarenal and suprarenal aneu-
ysms. Recent reports have highlighted this paradigm shift
n open aneurysm repair noting that up to 60% of open
neurysm repairs are for juxtarenal aneurysms; some reports
etail no deleterious effect of aneurysm complexity on
utcomes.8,9 Other investigators, however, have observed
hat this anatomic shift in open repair has resulted in
ncreased operative morbidity.10 Many single center expe-
iences from high volume centers have reported low mor-
ality and moderate morbidity for complex aneurysm re-
air; however, these reports are limited by cohort size, and
nclusion of data spanning decades of experience.11-16
ongkind et al17 recently published a systematic review on
utcomes of juxtarenal aneurysm repair. This review col-
ated outcomes from 21 published reports with a total of
256 patients and concluded that juxtarenal aneurysm
epair can be performed with acceptable mortality (2.9%)
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Volume 54, Number 4 Patel et al 953was, however, limited by the small number of studies
evaluated, the vast majority of which were single center
reports, and the long time span represented by most of the
included studies. The aim of this study was to evaluate the
outcomes of complex and infrarenal aortic aneurysm repair
in contemporary practice across a spectrum of hospital and
surgeon environments.
METHODS
Our study is a retrospective cohort study comparing
outcomes of patients undergoing complex aneurysm repair
to that of patients undergoing infrarenal abdominal aortic
aneurysm (AAA) repair using data from the National Sur-
gical Quality Improvement Program (NSQIP) Participant
Use File (PUF). The NSQIP (2005-2008) PUF includes
data from over 200 hospitals spanning the spectrum from
small private hospitals to large academic centers. At partic-
ipating hospitals, independent nurse auditors review elec-
tronic and paper records and prospectively enter patient
data on demographics (6 variables), surgical profile (11
variables), preoperative data (44 variables), intraoperative
variables (16), and 30-day postoperative outcomes (20) for
patients undergoing major procedures. Data are directly
entered into a secure website and completeness and accu-
racy of entered data are ensured and validated in a series of
prior publications.18-22 The NSQIP database captures the
above noted information for a variety of surgical proce-
dures; therefore, the preoperative and outcomes data col-
lected therein are not procedure or surgical speciality spe-
cific. Particulars of the clinical variables evaluated, 30-day
outcomes analyzed and study definitions are publically
available.23
The NSQIP PUF was queried to identify the two study
cohorts for comparison. Patients undergoing infrarenal
aneurysm (AAA) repair were identified using the CPT
codes (35081, 35102) for intact (nonruptured) abdominal
aortic aneurysm repair. Complex aneurysm (CAA) repair
patients were identified by the CPT code for repair of
nonruptured aneurysm involving the visceral vessels
(35091). The primary study objective entailed analysis of
operative mortality (primary end point), baseline clinical
features, and operative morbidity (secondary end points) in
patients undergoing AAA and CAA repair. Patients under-
going visceral vessel reconstruction (VVR) were identified
as those patients undergoing a primary AAA or CAA repair
who also underwent a concomitant aorto-visceral bypass
(celiac, mesenteric, or renal) (CPT 35631). Further ana-
lyzes were performed in patients with and without VVR to
evaluate the impact of VVR on clinical outcomes.
All ordinal data are presented as absolute number and
percent prevalence in the study population. All continuous
data are presented as mean  sd. Univariate analysis was
performed by using Fisher exact test for discrete variables,
the t test with equal variances for normally distributed
continuous variables, and the Wilcoxon rank sum test for
non-normally distributed continuous and ordinal variables.
Multivariate stepwise regression analyses were performed
to identify predictors of death and any complications, phich included cardiac complications, pulmonary compli-
ations, and renal complications. Results with a P  .05
ere considered statistically significant. Statistical data anal-
sis was performed using SAS version 9.1 (Cary, NC).
ESULTS
Using the NSQIP PUF, we identified 3569 patients
ho underwent repair of an intact open abdominal aortic
neurysm from January 1, 2005 to December 31, 2008.
ighty-three percent of patients (n  2820) underwent
epair of an infrarenal aortic aneurysm (AAA group),
hereas 17% of the cohort (n 592) underwent repair of a
omplex aneurysm involving the visceral vessels (CAA
roup). For comparison, 5813 patients were treated with
VAR during the study period. Baseline demographic and
linical features of the two study populations are detailed in
able I. Patients undergoing AAA repair were more likely
o have dependent functional status (defined as a patient
ho is totally dependent on assistance for all activities of
aily living), undergo emergency surgery (defined as need
or surgery within 12 hours of admission), and were less
ikely to be white and have a history of transient ischemic
ttack (TIA) (Table I). There were no significant differ-
nces in cardiovascular risk factors of age, gender, American
ociety of Anesthesiology (ASA) class, tobacco use, hyper-
ension, diabetes, stroke history, chronic obstructive pul-
onary disease (COPD), and coronary artery disease (Ta-
le I). The remainder of the baseline demographic and
linical features pertaining to systemic illness, nutritional
tatus, or patient physiological status was similarly distrib-
ted between the two study groups (Table I). Both groups
ere found to have similar baseline laboratory values, in-
luding a similar percentage of patients with abnormal
reatinine at baseline (31.1% AAA vs 30.6% CAA; P .84)
nd similar baseline nutritional status as reflected by serum
lbumin (g/dL) (3.9  0.6 AAA vs 3.9  0.6 CAA; P 
99). The mean baseline creatinine (mg/dL) was similar
P  .4) at 1.2  0.6 for AAA patients and 1.2  0.7 for
AA patients.
Thirty-day clinical outcomes captured in the NSQIP
UF data set are presented in Table II. Thirty-daymortality
as similar (P  .54) in the two groups with 5.1% of AAA
atients and 5.7% of CAA dying within 30 days of aneurysm
epair. Complex AAA repair was associated with increase in
perative time. Patients undergoing CAA repair were more
ikely to develop any complication and any major compli-
ation (defined as any complication not including urinary
ract infection and superficial wound infection). Cardiac
rrest requiring cardiopulmonary resuscitation (CPR) was
ore common in the CAA group. There were no differ-
nces between AAA and CAA patients with respect to other
0-day complications captured in the data set (Table II).
A total of 157 patients in our study population under-
ent a concomitant VVR, these being with either AAA
n 73) or CAA (n 84). As anticipated, patients under-
oing CAA repair were fourfold more likely to have a
oncomitant visceral vessel reconstruction compared with




















































JOURNAL OF VASCULAR SURGERY
October 2011954 Patel et alAAA; P  .001). To evaluate the particulars of patients
undergoing visceral vessel bypass, we further analyzed this
cohort in comparison to patients not requiring VVR. Table
III highlights the baseline demographic and clinical fea-








N (%) P value
Male 2092 (74.2) 425 (71.8) .24
White 1993 (70.7) 529 (89.5) .0088
Age (years) (mean  sd) 71  9.0 71.3  9.1 .51
BMI (mean  sd) 27.5  5.5 26.8  5.2 .23
Impaired sensorium 20 (0.7) 2 (0.3) .41
DNR status 17 (0.6) 2 (0.32) .55
Dependent functional
status 192 (6.8) 25 (4.2) .02
Chronic steroid use 89 (3.2) 17 (2.9) .8
Weight loss (10% in
6 months) 65 (2.3) 15 (2.5) .77
Recent operation
(30 days) 56 (2) 8 (1.4) .47
Emergency case 257 (9.1) 37(6.3) .023
ASA class 3 2656 (94.2) 548 (92.5) .16
Tobacco use 1170 (41.5) 244 (41.2) .93
Diabetes 344 (12.2) 62 (10.5) .26
HTN 2315 (82.1) 496 (83.8) .34
History of TIA 174 (6.2) 51 (8.6) .045
CVA 144 (5.1) 26 (4.4) .53
COPD 525 (18.6) 121 (20.4) .3
Dyspnea 705 (25) 147 (24.8) 1
CHF 20 (0.7) 5 (0.8) .79
MI 39 (1.4) 8 (1.4) 1
PCI 525 (18.6) 105 (17.7) .68
CABG 651 (23.1) 150 (25.3) .24
Angina 61 (2.2) 10 (1.7) .53
PVD 172 (6.1) 30 (5.1) .34
Rest pain or gangrene 54 (1.9) 10 (1.7) .87
Acute renal failure 8 (0.3) 4 (0.7) .14
Dialysis 23 (0.8) 5 (0.8) .80
Alcohol use 166 (5.9) 34 (5.7) .93
Ascites 3 (0.1) 0 1
Esophageal varices 3 (0.1) 1 (0.2) 1
Disseminated cancer 8 (0.3) 4 (0.7) .14
Chemotherapy (1
month)
10 (0.35) 2 (0.3) 1
Radiation therapy
(90 days) 4 (0. 4) 2 (0.3) 1
Wound infection 42 (1.5) 4 (0.7) .71
Pneumonia 8 (0.3) 1 (0.2) 1
Bleeding disorder 234 (8.3) 45 (7.6) .68
4 unit blood
transfusion (72 hours) 10 (0.4) 2 (0.3) 1
AAA, Infrarenal abdominal aortic aneurysm repair cohort; ASA, American
Society of Anesthesiology; BMI, body mass index (weight [kilograms]/
height [meters])2; CABG, previous coronary artery bypass graft; CHF,
congestive heart failure within prior 30 days; COPD, chronic obstructive
pulmonary disease; Complex, juxtarenal aneurysm repair cohort; CVA, cere-
brovascular accident or stroke; DNR, do not resuscitate; HTN, hyperten-
sion requiring medical therapy; MI, myocardial infarction within prior 6
months; PCI, previous percutaneous coronary intervention; PVD, periph-
eral vascular disease with previous revascularization or amputation; TIA,
transient ischemic attack.tures of patients undergoing VVR compared with those tndergoing aneurysm repairs without a visceral vessel by-
ass (no bypass cohort). Patients undergoing VVR were
ore likely to have a lower body mass index (BMI) and
ere less likely to have poor functional status, require
mergency surgery, and to have dyspnea as a symptom.
aseline laboratory values were similar in patients with
VR and those with no bypass with the exception of higher
ercentage of VVR patients having abnormal creatinine
51% VVR vs 31% no bypass; P  .001). The baseline
reatinine (mg/dL) was higher (P  .032) at 1.33  0.54
or VVR patients compared with 1.21  0.7 for patients
ithout VVR. VVR was associated with prolonged opera-
ive time and postoperative length of stay (Table IV). There
as a trend toward increasedmortality associated with VVR
8.9% VVR vs 5.2% no bypass; P  .067). VVR was also
ssociated with an increase in major complications, postop-
rative pneumonia, unplanned intubation, prolonged ven-








N (%) P value
hirty-day mortality 143 (5.1) 38 (5.7) .54
perative time (minutes)
(mean sd) 224  92 254  100 .001
ost-op length of stay
(days) (mean  sd) 9.5  10.1 9.5  8.7 .98
ny complication 764 (27.1) 191 (32.3) .011
ny major complication 826 (29.3) 200 (33.8) .03
uperficial infection 56 (2) 16 (2.7) .27
eep infection 20 (0.7) 3 (0.5) .78
rgan space infection 20 (0.7) 4 (0.7) 1
ound dehiscence 42 (1.5) 9 (1.5) 1
ost-op pneumonia 262 (9.3) 55 (9.3) 1
nplanned intubation 206 (7.3) 52 (8.8) .23
ulmonary embolus 14 (0.5) 3 (0.5) 1
entilator 48 hours 330 (11.7) 78 (13.2) .33
rogressive renal
insufficiency 79 (2.8) 21 (3.6) .35
cute renal failure - HD 110 (3.9) 30 (5.1) .21
rinary tract infection 96 (3.4) 24 (4.1) .46
VA with deficit 25 (0.9) 6 (1) .64
oma 24 hours 11 (0.4) 2 (0.3) 1
eripheral nerve injury 11 (0.4) 0 .24
ardiac arrest requiring
CPR 45 (1.6) 22 (3.7) .0017
yocardial infarction 25 (0.9) 6 (1) .81
leeding requiring
transfusion 90 (3.2) 25 (4.2) .21
raft failure 23 (0.8) 7 (1.2) .34
VT/thrombophlebitis 17 (0.6) 4 (0.7) .84
epsis 141 (5) 24 (4) .35
eptic shock 175 (6.2) 39 (6.6) .71
eturn to operating
room (30 days) 259 (9.2) 58 (9.8) .64
AA, Infrarenal abdominal aortic aneurysm repair cohort; Any complica-
ion, all complications; CPR, cardiopulmonary resuscitation; Complex, jux-
arenal aneurysm repair cohort; CVA, cerebrovascular accident or stroke;
VT, deep venous thrombosis; HD, hemodialysis; Major complications, all
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Volume 54, Number 4 Patel et al 955cardiac arrest requiring CPR, deep venous thrombosis
(DVT), and septic shock (Table IV).
Multivariate regression modeling was used to identify
independent predictors of operative mortality and major
complications. Complex aneurysm repair (odds ratio [OR],
1.2 [95% confidence interval, CI, 0.84-1.8]; P  .3) and
visceral vessel reconstruction (OR, 1.6 [95% CI, 0.89-2.9];
P  .11) were not identified as independent predictors of
mortality even when forced into themodel. Poor functional
status, preoperative creatinine, history of TIA, type II dia-
Table III. Demographic and preoperative clinical











Male 2525 (73.7) 106 (67.5) .096
White 2941 (86.2) 141 (89.8) .23
Age (years) (mean  sd) 71.1  9.0 71.9  8.6 .26
BMI (mean  sd) 27.5  5.5 25.7  4.7 .001
Impaired sensorium 21 (0.64) 0 .62
DNR status 20 (0.59) 1 (0.64) .61
Dependent functional
status 218 (6.4) 4 (2.6) .06
Chronic steroid use 106 (3.1) 4 (2.6) 1
Weight loss (10% in
6 months) 81 (2.4) 4 (2.6) .79
Recent operation (30
days)
64 (1.9) 4 (2.6) .73
Emergency case 293 (8.6) 6 (3.8) .038
ASA class 3 3203 (93.9) 145 (92.4) .4
Tobacco use 1412 (41.4) 70 (44.6) .46
Diabetes 406 (11.9) 18 (11.5) 1
HTN 2811 (82.4) 136 (86.6) .2
History of TIA 228 (6.7) 15 (9.6) .19
CVA with deficit 171 (5) 10 (6.4) .45
CVA with NO deficit 171 (5) 5 (3.2) .45
COPD 649 (18.9) 30 (19.1) .92
Dyspnea 850 (24.9) 27 (17.2) .029
CHF 26 (0.76) 3 (1.91) .13
MI 47 (1.4) 0 .27
PCI 627 (18.4) 9 (18.5) 1
CABG 801 (23.5) 45 (28.7) .15
Angina 72 (2.1) 2 (1.3) .77
PVD 203 (6) 11 (7) .60
Rest pain or gangrene 63 (1.9) 3 (1.9) .77
Acute renal failure 11 (0.35) 0 1
Dialysis 27 (0.79) 3 (1.9) .14
Alcohol use 201 (6) 5 (3.2) .21
Wound infection 51 (1.5) 4 (2.6) .31
Pneumonia 9 (0.26) 0 1
Bleeding disorder 280 (8.2) 7 (4.5) .099
4 unit blood transfusion
(72 hours) 14 (0.4) 0 1
ASA, American Society of Anesthesiology; BMI, body mass index (weight
[kilograms]/height [meters])2; CABG, previous coronary artery bypass
graft; CHF, congestive heart failure within prior 30 days; COPD, chronic
obstructive pulmonary disease; CVA, cerebrovascular accident or stroke;
DNR, do not resuscitate; HTN, hypertension requiring medical therapy;
MI, myocardial infarction within prior 6 months; PCI, previous percutane-
ous coronary intervention; PVD, peripheral vascular disease with previous
revascularization or amputation; TIA, transient ischemic attack.betes, and age (as a continuous variable) were independent aredictors of mortality (Table V). Independent predictors
f any major postoperative complication included complex
neurysm (CAA) repair (OR, 1.3 [95% CI, 1.1-1.6]; P 
01), VVR (OR, 2.2 [95% CI, 1.8-3.6]; P  .01), poor
unctional status (OR, 2.3 [95% CI, 1.7-3.1]; P  .01),
mergency surgery (OR, 2.2 [95% CI, 1.7-2.8]; P  .01),
able IV. Clinical outcomes for patients with and







N (%) P value
perative time
(minutes)
(mean  sd) 230  95 320  130 .0001
ost-op length of stay
(days) (mean  sd) 9.5  9.8 12.6  13.3 .0001
eath 177 (5.2) 14 (8.9) .067
ny complication 955 (28) 73 (46.5) .0001
ny major complication 873 (25.6) 67 (42.7) .0001
uperficial infection 71 (2.1) 2 (1.3) .77
eep infection 23 (0.67) 2 (1.3) .30
rgan space infection 24 (0.7) 3 (1.9) .12
ound dehiscence 50 (1.5) 2 (1.3) 1
ost-op pneumonia 317 (9.3) 27 (17.2) .0022
nplanned intubation 259 (7.6) 24 (15.3) .0013
ulmonary embolus 17 (0.5) 1 (0.6) .58
entilator 48 hours 409 (12) 33 (21) .0017
rogressive renal
insufficiency
102 (3) 11 (7) .015
cute renal failure - HD 140 (4.1) 12 (7.6) .041
rinary tract infection 123 (3.6) 7 (4.5) .51
VA with deficit 31 (0.9) 2 (1.3) .65
oma 24 hours 14 (0.4) 0 1
eripheral nerve injury 14 (0.4) 0 1
ardiac arrest requiring
CPR 68 (2) 11 (7) .0005
yocardial infarction 31 (0.9) 4 (2.6) .066
leeding requiring
transfusion 116 (3.4) 9 (5.7) .12
raft failure 30 (0.88) 2 (1.3) .65
VT/thrombophlebitis 51 (1.5) 6 (3.8) .0082
epsis 167 (4.9) 11(7) .25
eptic shock 214 (6.3) 21 (13.4) .0014
eturn to operating
room
(30 days) 317 (9.3) 20 (12.7) .16
AA, Infrarenal abdominal aortic aneurysm repair cohort; Any complica-
ion, all complications; Complex, juxtarenal aneurysm repair cohort; CPR,
ardiopulmonary resuscitation; CVA, cerebrovascular accident or stroke;
VT, deep venous thrombosis; HD, hemodialysis; Major complications, all
omplications excluding UTI and superficial infection.
able V. Multivariate predictors of operative mortality
ariable Odds ratio 95% CI P value
oor functional status 3.6 2.3-5.4 .01
reoperative creatinine 2.9 2.2-4.0 .01
ransient ischemic attack 1.7 1.03-2.8 .04
ype II diabetes 1.6 1.05-2.4 .03
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October 2011956 Patel et alsmoking (OR, 1.2 [95% CI, 1.06-1.5]; P  .01), and age
(OR, 1.02 [95% CI, 1.01-1.03]; P  .01).
DISCUSSION
The number of patients undergoing CAA repair in
contemporary practice has been reported to be increasing
with up to 60% of open aneurysm repairs being juxtarenal in
nature by some investigators.9 Other investigators have
noted a modest increase (20%) in the fraction of complex
(juxtarenal, pararenal, and suprarenal) aneurysm anatomy
in their current practice.8,10 Costin et al noted an increase
in the proportion of juxtarenal aneurysms being repaired to
20% in the post stent graft era compared with 6% in the
years prior to stent graft availability.8 In the present study,
20% of open aneurysm repairs were complex in nature
consistent with the above cited studies. The argument for
an evolving selection bias of straightforward aneurysm
morphology to EVAR is valid and the contemporary frac-
tion of 20% CAA repairs likely reflects a significant increase
from prior practice. Specific conclusions regarding changes
in practice to more CAA performed in contemporary prac-
tice cannot be drawn using the NSQIP PUF as hospital
specific information is not available and the number of
hospitals contributing to the data set is increasing. Cur-
rently, over 200 hospitals spanning the spectrum of hospital
type from small private hospitals to major academic centers
with a 3:2 (academic: private) ratio participate in the private
sector NSQIP. This data set therefore reflects a “real
world” experience and the majority (80%) of contempo-
rary open aneurysm repair is still performed for infrarenal
aneurysms.
Reconstruction of complex aneurysms compared with
infrarenal aneurysm repair involves a more proximal aortic
dissection and cross clamp application and in some cases
visceral vessel (predominantly renal) reconstruction either
with endarterectomy, reimplantation, or a bypass graft. The
attendant risks of a more proximal suprarenal clamp or
supravisceral clamp include increased cardiovascular strain
and/or obligatory periods of mesenteric and/or renal isch-
emia with their potential sequelae. Atheroembolization
Table VI. Summary of outcomes for complex aneurysm r
Reference Patients Dates Types o
Crawford24 101 — JRA
Jean-Claude25 257 1977-1997 JRA, SR
Sarac26 138 1994-2000 JRA
Shortell27 112 1991-2001 JRA
Chiesa11 119 1993-2005 JRA, SR
West12 247 1993-2003 JRA
Pearce13 150 1996-2006 JRA, SR
Knott14 126 2001-2006 JRA
Landry10 82 2000-2007 JRA
Chong16 171 1990-2006 JRA
Jongkind17 1251 1986-2006 JRA
Current series 676 2004-2007 JRA, SR
HD, Hemodialysis; JRA, juxtarenal aneurysm; RAOD, renal artery occlusivfrom surgical dissection or clamp application may further pxacerbate such complications. CAA accordingly has been
ssociated with increased morbidity and mortality com-
ared with that of infrarenal AAA repair. Indeed, the earli-
st reported series of 101 patients undergoing juxtarenal
neurysm repair by Crawford et al noted an operative
ortality rate of 7.9% and postoperative renal failure rate of
%.24 Similarly, even referral centers with expertise have
eported a operative mortality of 5.8% in their series of 247
omplex aneurysm repairs, which included juxtarenal and
uprarenal aneurysms as well as patients with juxtarenal
neurysms who underwent concomitant treatment of renal
rtery occlusive disease.25 They reported postoperative re-
al insufficiency occurring in 41% of patients with 7% of
atients requiring hemodialysis, the incidence of which was
tatistically associated with prolonged renal ischemia
ime.25 Clinical outcomes of complex aortic aneurysm re-
air highlighting mortality and renal morbidity as reported
y other single center series are summarized in Table VI.
This study was performed to evaluate the outcomes of
omplex aneurysm repair using a contemporary data set and
o compare the clinical outcomes of CAA repair with those
f infrarenal AAA repair. Our primary study outcome was
perative mortality, the rates of which were 5.1%, 5.7%, and
.9% for AAA, CAA, and VVR, respectively. The recorded
ortality rate of 5.1% for AAA is higher than that reported
y many single center reports from high volume referral
enters.28,29 However, several multicenter prospective ran-
omized trials evaluating operative mortality of AAA re-
air, including the UK small aneurysm trial30 (5.8%),
VAR 131 (6.2%), and DREAM 132 (4.6%) trials reported
ortality rates for open AAA repair similar to that reported
erein. Other large database studies reflecting nationwide
utcomes have also reported similar operative mortality
ates for AAA repair.33 With respect to operative mortality
ssociated with CAA repair, our rate of 5.7% is comparable
o other reported rates (Table VI), however, on the higher
nd of the range of reported mortalities. Unlike these other
tudies where aneurysm morphology was evaluated with
T scan and where technical details regarding clamp loca-
ion and duration were available, our study identified com-
ir Renal complications Mortality
HD 7.9% 7.9%
OD RI 41%/HD 7% 5.8%
RI 28%/HD 5.8% 5.1%
RI 12%/HD 3% 6%
RI 18%/HD 3.5% 4.2%
RI 22%/ HD 3.7% 2.5%
RI 14%/HD 7% 3%
RI 18%/HD 4% 0.8%
RI 29%/HD 6% 6.1%
RI 17%/HD 0.6% 1.8%
RI 0-39% HD 3.3% (2.4-4.5) 3.3% (1.8-4.6)
RI 3.7%/HD 6.1% 6.4%
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Volume 54, Number 4 Patel et al 957abdominal aortic aneurysm involving the visceral vessels
(CPT 35091). As such, our data set likely includes juxtare-
nal and suprarenal aneurysms in the cohort of CAA. The
majority of studies listed in Table VI reported on outcomes
of juxtarenal aneurysm repair alone or reported the ratio of
juxtarenal to suprarenal and reported overall as well as
aneurysm-type specific outcomes. The relative distribution
of juxtarenal/suprarenal in our data set is unknown as
vascular specific technical details such as cross clamp loca-
tion and outcomes are not collected in the NSQIP PUF.
Several investigators have noted higher operative mortality
associated with suprarenal aneurysm repair compared with
juxtarenal,13 which may be reflective of the findings of
others who have noted higher morbidity and mortality
associated with supravisceral clamp application compared
with suprarenal clamping12,26,34 as suprarenal aneurysm
repair is more commonly performed with a supravisceral
clamp. Inclusion of such information in our study would
have possibly helped assess the mortality figure with more
granularity and explain our outcomes relative to those of
others.
In our study, VVR was more commonly performed in
conjunction with CAA (12%) compared with AAA
(2.5%). The rates of VVR reported herein likely underesti-
mate the number of patients actually undergoing VVR as
most investigators note that endarterectomy is the most
common (50%) renal revascularization procedure per-
formed in conjunction with open aneurysm reconstruc-
tion.12,14,25,27,35 The procedure code for aorto-visceral
bypass is therefore not likely to have captured such patients,
a limitation that could have been overcome with vascular
specific technical details. The mortality rate of 8.9% for
patients in our series is similar to that reported by others.
Sarac et al reported that VVR was necessary in 27% of
patients and was associated with an 8.1% operative
mortality.26
Our data indicate similar operative mortality for AAA
compared with CAA repair. Comorbidity profiles between
AAA and CAA were for the most part similar. Practical
considerations of operation such as functional status or
emergency procedures could have increased the mortality
for AAA repair; however, analysis of the data with exclusion
of emergency procedures resulted in similar conclusions.
Patients undergoing VVR hadmany of the same differences
in baseline clinical features and demographics, which may
have influenced mortality. Despite baseline differences, our
regression analysis did not identify CAA or VVR as inde-
pendent predictors of mortality even when these factors
were forced into the logit equation. We identified poor
functional status, preoperative creatinine value, history of
TIA, type II diabetes, and age as independent predictors of
mortality for open aneurysm repairs inclusive of AAA or
CAA and including patients requiring VVR. Other investi-
gators have reported poor functional status, baseline creat-
inine, age, and diabetes as predictors of operative mortality
in open and complex aneurysm repair.12,13,16,36 Landry et
al have recently reported comparable mortality rates asso-
ciated with AAA and CAA repair10 and low mortality rates Pssociated with renal artery revascularization.37 Our own
nstitutional experience has also noted the safety of simul-
aneous renal artery revascularization during aortic sur-
ery.38 A recent report by Martin et al39 comparing the
utcomes of AAA repair using the National Inpatient Sam-
le (NIS) to that of patients undergoing simultaneous AAA
epair and visceral or renal bypass (VRB) reported a signif-
cant increase in mortality associated with VRB (5.8% VRB
s 4.4%). Their VRB cohort was derived in a fashion similar
o our VVR group. They, however, compared only infrare-
al AAA repair with the VRB group, whereas we compared
AA and CAA patients without a visceral/renal bypass to
he VVR group which may explain the reported difference.
n alternative explanation for the differences in significance
ay reflect the statistical power associated with their study
hich included 41,166 VRB patients compared with
62,808 AAA patients.
Our study showed operative morbidity to be signifi-
antly associated with operative complexity. Patient under-
oing CAA and VVR were noted to have increasingly
igher rates of major complications. The overall increase in
omplications associated with CAA was influenced by car-
iac, pulmonary, and renal complications with similar rates
eported by other investigators.11-15,25-27 This is consistent
ith the theoretic increase in risk associated with the tech-
ical challenges of complex aneurysm repair, a more prox-
mal clamp application and the attendant renal and/or
isceral ischemia. Patients undergoing VVR had the highest
requency of major complication, which were also influ-
nced by cardiac, pulmonary, and renal complications (Ta-
le VI). VVR was also associated with increased incidence
f septic shock that may be reflective of supravisceral clamp
pplication and prolonged visceral ischemia times. Both
actors have been reported by others to be associated with
ultiorgan failure.11,24
The major limitation of this study is related to the
eficiencies of the NSQIP data set. The PUF was designed
nd implemented with quality improvement for a broad
ange of surgical procedures in mind. The data set therefore
ncludes a significant number of perioperative variables for
he study of surgical outcomes that adds to its strengths.
he data are, however, limited in that no speciality-specific
ata are included for analysis. In our study of outcomes for
nfrarenal and complex abdominal aortic aneurysms, addi-
ional data on anatomic distinction as to the exact nature of
he complex aneurysm (juxtarenal vs suprarenal), location
f the aortic clamp, renal and visceral ischemia times, and
he specific type of visceral revascularization among others
ould have strengthened our analysis. As a result of this
imitation, we defined our study cohorts using procedure
PT codes (defined by the surgeon operative note) to infer
neurysm anatomy, but more importantly, the complexity
f aortic reconstruction. For patients with infrarenal AAA,
ategorization into the AAA group was likely straightfor-
ard using CPT coding. Similarly, patients with aneurysms
xtending to and above the renal arteries were also appro-
riately categorized into the complex aneurysm group.
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ity to renal arteries, clamp location, and need for renal
artery revascularization among others. Such a limitation
could have been avoided using specific anatomic details.
Information regarding the type of hospital, hospital vol-
ume, and surgeon volume are also features that have been
reported to impact outcomes of aneurysm repair and are
not available in this data set.40 Despite these limitations the
data set has numerous strengths some of which include the
large number of patients included, the independent acqui-
sition of outcomes data, and the validation schema to
ensure integrity. Additionally, the data represent a contem-
porary (2005-2008) experience unlike that reported in the
referenced single center reports which include data span-
ning decades of experience.
Our study collating contemporary data from a spec-
trum of hospital and surgeons with a range of experience
and volume show that complex aneurysm repair can be
safely performed without increases in operative mortality.
The implication of these data when open surgery has be-
come the surgery of complex AAA is clear. The complexity
of operative reconstruction does, however, result in in-
creased operative morbidity, although the data relative to
postoperative renal complications are very encouraging.
Finally, the data relative to independent correlates of oper-
ative mortality should assist surgeons in clinical decision
making.
AUTHOR CONTRIBUTIONS
Conception and design: VP, RL, RC
Analysis and interpretation: VP, RL,MC, GL, CK, DB, RC
Data collection: VP, RL
Writing the article: VP, RL, RC
Critical revision of the article: VP, RL, MC, GL, CK, DB,
RC
Final approval of the article: VP, RL,MC, GL, CK,DB, RC
Statistical analysis: VP, RL
Obtained funding: Not applicable
Overall responsibility: VP
REFERENCES
1. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft
implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:
491-9.
2. Brewster DC, Jones JE, Chung TK, LaMuraglia GM, Kwolek CJ,
Watkins MT, et al. Long-term outcome after endovascular abdominal
aortic aneurysm repair: the first decade. Ann Surg 2006;244:426-38.
3. Giles KA, Pomposelli F, Hamdan A, Wyers M, Jhaveri A, Schermerhorn
ML, et al. Decrease in total aneurysm-related deaths in the era of
endovascular aneurysm repair. J Vasc Surg 2009;49:543-51.
4. Schwarze ML, Shen Y, Hemmerich J, Dale W. Age-related trends in
utilization and outcome of open and endovascular repair for abdominal
aortic aneurysm in the United States, 2001-2006. J Vasc Surg 2009;50:
722-9.
5. Jordan WD, Moore WM, Melton JG, Brown OW, Carpenter JP, et al
for the Endologix Investigators. Secure fixation following EVAR with
the Powerlink XL System in wide aortic necks: results of a prospective,
multicenter trial. J Vasc Surg 2009;50:979-86.
6. Jim J, Sanchez LA, Rubin BG, Criado FJ, Fajardo A, Geraghty PJ, et al.
A 5-year evaluation using the Talent endovascular graft for endovascular
aneurysm repair in short aortic necks. Ann Vasc Surg 2010;24:851-8.7. Turnbull IC, Criado FJ, Sanchez L, Sadek M,Malik R, Ellozy SH, et al.
Five-year results for the Talent enhanced low profile system abdominal
stent graft pivotal trial including early and long-term safety and efficacy.
J Vasc Surg 2010;51:537-44.
8. Costin JA, Watson DR, Duff SB, Edmonson-Holt A, Shaffer L, Blos-
som GB, et al. Evaluation of the complexity of open abdominal aneu-
rysm repair in the era of endovascular stent grafting. J Vasc Surg
2006;43:915-20.
9. Albuquerque FC, Tonnessen BH, Noll RE, Cires G, Kim JK, Stern-
bergh WC, et al. Paradigm shifts in the treatment of abdominal aortic
aneurysm: trends in 721 patients between 1996 and 2008. J Vasc Surg
2010;51:1348-53.
0. Landry G, Lau I, Liem T, Mitchell E, Moneta G. Open abdominal
aortic aneurysm repair in the endovascular era: effect of clamp site on
outcomes. Arch Surg 2009;144:811-6.
1. Chiesa R, Marone EM, Brioschi C, Frigerio S, Tshomba Y, Melissano
G, et al. Open repair of pararenal aortic aneurysms: operative manage-
ment, early results, and risk factor analysis. Ann Vasc Surg 2006;20:
739-46.
2. West CA, Noel AA, Bower TC, Cherry KJ, Gloviczki P, Sullivan TM, et
al. Factors affecting outcomes of open surgical repair of pararenal aortic
aneurysms: a 10-year experience. J Vasc Surg 2006;43:921-8.
3. Pearce JD, EdwardsMS, Stafford JM,Deonanan JK,Davis RP, Corriere
MA, et al. Open repair of aortic aneurysms involving the renal vessels.
Ann Vasc Surg 2007;21:676-86.
4. Knott AW, Kalra M, Duncan AA, Reed NR, Bower TC, Hoskins TC, et
al. Open repair of juxtarenal aortic aneurysms (JAA) remains a safe
option in the era of fenestrated endografts. J Vasc Surg 2008;47:695-
701.
5. Ockert S, Schumacher H, Bockler D, Malchereck K, Hansmann J,
Allenberg J. Comparative early and midterm results of open juxtarenal
and infrarenal aneurysm repair. Langenbecks Arch Surg 2007;392:
725-30.
6. Chong T, Nguyen L, Owens CD, Conte MS, Belkin M. Suprarenal
aortic cross-clamp position: a reappraisal of its effects on outcomes for
open abdominal aortic aneurysm repair. J Vasc Surg 2009;49:873-80.
7. Jongkind V, Yeung KK, Akkersdijk GJ, Heidsieck D, Reitsma JB,
Tangelder GJ, et al. Juxtarenal aortic aneurysm repair. J Vasc Surg
2010;52:760-7.
8. Sharp WJ, Bashir M, Word R, Nicholson R, Bunch C, Corson J, et al.
Suprarenal clamping is a safe method of aortic control when infrarenal
clamping is not desirable. Ann Vasc Surg 2008;22:534-40.
9. Khuri SF, Daley J, Henderson W, Hur K, Gibbs JO, Barbour G, et al.
Risk adjustment of the postoperative mortality rate for the comparative
assessment of the quality of surgical care: Results of the National
Veterans Affairs Surgical Risk Study. J AmColl Surg 1997;185:315-27.
0. Khuri SF, Daley J, Henderson W, Barbour G, Lowry P, Irvin G, et al.
The National Veterans Administration Surgical Risk Study: risk adjust-
ment for the comparative assessment of the quality of surgical care. J Am
Coll Surg 1995;180:519-31.
1. Daley J, Khuri SF, Henderson W, Hur K, Gibbs JO, Barbour G, et al.
Risk adjustment of the postoperative morbidity rate for the comparative
assessment of the quality of surgical care: results of the National
Veterans Affairs Surgical Risk Study. J AmColl Surg 1997;185:328-40.
2. Daley J, Forbes MG, Young GJ, Charns MP, Gibbs JO, Hur K, et al.
Validating risk-adjusted surgical outcomes: site visit assessment of pro-
cess and structure. National VA Surgical Risk Study. J Am Coll Surg
1997;185:341-51.
3. ACS. NSQIP Web site: Available at: http://www.acsnsqip.org/puf/
docs/ACS_NSQIP_Participant_User_Data_File_User_Guide.pdf. Ac-
cessed August 31, 2010.
4. Crawford ES, Beckett WC, Greer MS. Juxtarenal infrarenal abdominal
aortic aneurysm. Special diagnostic and therapeutic considerations. Ann
Surg 1986;203:661-70.
5. Jean-Claude JM, Reilly LM, Stoney RJ, Messina LM. Pararenal aortic
aneurysms: the future of open aortic aneurysm repair. J Vasc Surg
1999;29:902-12.
6. Sarac TP, Clair DG,Hertzer NR, Greenberg RK, Krajewski LP, O’Hara








JOURNAL OF VASCULAR SURGERY
Volume 54, Number 4 Patel et al 95927. Shortell CK, Johansson M, Green RM, Illig KA. Optimal operative
strategies in repair of juxtarenal abdominal aortic aneurysms. Ann Vasc
Surg 2003;17:60-5.
28. Conrad MF, Crawford RS, Pedraza JD, Brewster DC, Lamuraglia GM,
Corey M, et al. Long-term durability of open abdominal aortic aneu-
rysm repair. J Vasc Surg 2007;46:669-75.
29. Hertzer NR, Mascha EJ, Karafa MT, O’Hara PJ, Krajewski LP, Beven
EG, et al. Open infrarenal abdominal aortic aneurysm repair: the
Cleveland Clinic experience from 1989 to 1998. J Vasc Surg 2002;35:
1145-54.
30. The UK Small Aneurysm Trial Participants. Mortality results for ran-
domized controlled trial of early elective surgery or ultrasonographic
surveillance for small abdominal aortic aneurysms. Lancet 1998;353:
1649-55.
31. Greenhalgh RM, Brown LC, Kwong GP, et al. Comparison of endo-
vascular aneurysm repair with open repair in patients with abdominal
aortic aneurysm (EVAR trial 1), 30-day operative mortality results:
randomised controlled trial. Lancet 2004;364:843-48.
32. Prinssen M, Verhoeven EL, Buth J, Cuypers PW, van Sambeek MR,
Balm R, et al. A randomized trial comparing conventional and endo-
vascular repair of abdominal aortic aneurysms. N Engl JMed 2004;351:
1607-18.
33. Schermerhorn ML, O’Malley AJ, Jhaveri A, Cotterill P, Pomposelli
F, Landon BE, et al. Endovascular vs. open repair of abdominal
aortic aneurysms in the Medicare population. N Engl J Med 2008;
358:464-74. S4. BackMR, BandykM, BradnerM, CuthbertsonD, Johnson BL, Shames
ML, et al. Critical analysis of outcome determinants affecting repair of
intact aneurysms involving the visceral aorta. Ann Vasc Surg 2005;19:
648-65.
5. Kashyap VS, Cambria RP, Davison JK, L’Italien GJ. Renal failure after
thoracoabdominal aortic surgery. J Vasc Surg 1997;26:949-55.
6. Hua HT, Cambria RP, Chuan SK, Stoner MC, Kwolek CJ, Rowell
KS, et al. Early outcomes of endovascular versus open abdominal
aortic aneurysm repair in the National Surgical Quality Improvement
Program-Private Sector (NSQIP-PS). J Vasc Surg 2005;41:382-9.
7. Landry GJ, Lau IH, Liem TK, Mitchell EL, Moneta GL. Adjunctive
renal artery revascularization during juxtarenal and suprarenal abdom-
inal aortic aneurysm repairs. Am J Surg 2010;199:641-5.
8. Cambria RP, Brewster DC, L’Italien G, Koustas G, Atamanian G,
LaMuraglia GM, et al. Simultaneous aortic and renal artery reconstruc-
tion: evolution of an eighteen year experience. J Vasc Surg 1995;21:
916-24.
9. Martin MC, Giles KA, Pomposelli FB, Hamdan AD, Wyers MC,
Schermerhorn ML, et al. National outcomes after open repair of ab-
dominal aortic aneurysms with visceral or renal bypass. Ann Vasc Surg
2010;24:106-12.
0. Eckstein HH, Bruckner T, Heider P, Wolf O, Hanke M, Niedermeir
HP, et al. The relationship between volume and outcome following
elective open repair of abdominal aortic aneurysms (AAA) in 131
German hospitals. Eur J Vasc Endovasc Surg 2007;34:260-6.ubmitted Nov 8, 2010; accepted Mar 7, 2011.
